{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:49:22Z","timestamp":1793832562670,"version":"4.6.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lupus nephritis (LN), the most severe renal complication in systemic lupus erythematosus (SLE), features inflammatory cascades from dysregulated cytokine networks. Although IL-18 (a pyroptosis effector) critically contributes to kidney inflammation, its dynamic changes across LN renal pathological stages and clinical correlations require systematic investigation. This meta-analysis explores peripheral blood IL-18\u2019s association with renal pathological damage in LN, providing molecular insights into inflammatory signaling network imbalances.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design and methods<\/jats:title><jats:p>This meta-analysis was performed to quantitatively assess the relationship between circulating IL-18 levels and lupus nephritis (LN) in SLE patients, incorporating stratified analyses by renal histopathological classifications (WHO classes II, III, IV, and V) to evaluate disease progression markers. We systematically queried multiple biomedical databases including PubMed, Embase, Scopus, Web of Science Core Collection, Wiley Online Library, MEDLINE, and Cochrane Library, encompassing all articles published before July 10, 2025. We pooled computed standardized mean difference (SMD) and its 95% confidence interval for meta-analytical using STATA 18.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 18 eligible studies were included, 1,033 SLE with LN, 537 SLE without LN, and 1,083 matched healthy controls. The analysis results displayed that LN patients showed a significantly higher level of circulating IL-18 level in comparison with healthy controls (SMD = 2.51, 95% CI [1.91-3.12];I2 = 96.2%, p=0.000). The conclusion was equally applicable in subgroups divided based on sample type, mean age, disease duration, and testing method. SLE with LN patients showed a significantly higher level of circulating IL-18 level than SLE without LN(SMD = 1.53 95% CI [0.87\u20132.20]; I\u00b2 = 95.7%, p =0.000). Compared with other classifications of LN, IV-LN patients demonstrate the highest serum IL-18 levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study reveals elevated IL-18 in LN patients, establishing it as a risk biomarker for SLE renal injury. The findings provide molecular evidence for IL-18 signaling imbalance in kidney inflammation and highlight therapeutic potential in targeting IL-18 to combat LN progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1631728","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:28:51Z","timestamp":1760074131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-18 in lupus nephritis: a meta-analysis of cytokine signaling dysregulation in immune-mediated nephropathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Cheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030090","article-title":"Comparison of mortality and its causes in patients with complicated systemic lupus erythematosus on hemodialysis versus peritoneal dialysis: A meta-analysis","volume":"101","author":"Gou","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221270","article-title":"From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift","volume":"81","author":"Parodis","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03400412","article-title":"Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis","volume":"8","author":"Giannico","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","article-title":"Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"185","author":"Mistry","year":"2017","journal-title":"Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673255656231003111621","article-title":"Research progress of pyroptosis in renal diseases","volume":"31","author":"Hu","year":"2024","journal-title":"Curr Med Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720877","article-title":"Novel effects of combination therapy through inhibition of caspase-1\/gasdermin D induced-pyroptosis in lupus nephritis","volume":"12","author":"Cao","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.621300","article-title":"Role of NLRP3 inflammasome in lupus nephritis and therapeutic targeting by phytochemicals","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-024-01351-x","article-title":"The effect of circulating cytokines on the risk of systemic lupus erythematosus: Mendelian randomization and observational study","volume":"76","author":"Xue","year":"2024","journal-title":"Immunogenetics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.05.001","article-title":"Inflammasomes and human autoimmunity: A comprehensive review","volume":"61","author":"Yang","year":"2015","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2336094100","article-title":"IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease","volume":"100","author":"Boss\u00f9","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.084","article-title":"The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis","volume":"1051","author":"Tucci","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B14","article-title":"Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis","volume":"3","author":"Liang","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319834677","article-title":"Impact of functional IL-18 polymorphisms on genetic predisposition and diverse clinical manifestations of the disease in Indian SLE patients","volume":"28","author":"Umare","year":"2019","journal-title":"Lupus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7507\/1672-2531.20150221","article-title":"A suite of network commands in stata for network meta-analysis","volume":"15","author":"Zhang","year":"2015","journal-title":"Chin J Evidence-Based Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00091-8","article-title":"Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis","volume":"9","author":"Wankhede","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001584","article-title":"Residual disease threshold after primary surgical treatment for advanced epithelial ovarian cancer, part 1: A systematic review and network meta-analysis","volume":"30","author":"Bryant","year":"2023","journal-title":"Am J Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01250","article-title":"Analysis of serum interleukin (IL)-1\u03b2 and IL-18 in systemic lupus erythematosus","volume":"9","author":"Mende","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1609-9","article-title":"Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis","volume":"32","author":"Liu","year":"2012","journal-title":"Rheumatol Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.23186","article-title":"Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18","volume":"58","author":"Tucci","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02588.x","article-title":"Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis","volume":"138","author":"Calvani","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4927530","DOI":"10.1155\/2016\/4927530","article-title":"Serum cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: from a Southern Chinese Han population","volume":"2016","author":"Sigdel","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1386-6","article-title":"Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients","volume":"29","author":"Hu","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0471-2","article-title":"High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus","volume":"22","author":"Shimizu","year":"2012","journal-title":"Mod Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01989.x","article-title":"Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus","volume":"130","author":"Wong","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e5037","DOI":"10.1097\/MD.0000000000005037","article-title":"Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients","volume":"95","author":"Wu","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B32","article-title":"Estimation of some immunological markers of Iraqi patients in systemic lupus erythematosus with lupus nephritis","volume":"20","author":"Ibrahim","year":"2020","journal-title":"Medico Legal Update"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15171\/jnp.2016.05","article-title":"Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus","volume":"5","author":"Jafari-Nakhjavani","year":"2016","journal-title":"J Nephropathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5606\/ArchRheumatol.2015.4675","article-title":"Interleukin-18 as a biomarker of subclinical lupus nephritis","volume":"30","author":"Bakry","year":"2015","journal-title":"Arch Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.07.004","article-title":"Serum cytokine profile in patients with active lupus nephritis","volume":"60","author":"Koenig","year":"2012","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejr.2012.09.005","article-title":"Serum interleukin-18 levels in patients with systemic lupus erythematosus: Relation with disease activity and lupus nephritis","volume":"35","author":"Mohsen","year":"2013","journal-title":"Egyptian Rheumatologist"},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0961203308094559","article-title":"Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis","volume":"18","author":"Chen","year":"2009","journal-title":"Lupus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102007","DOI":"10.1016\/j.jksus.2022.102007","article-title":"Cytokines and autoantibodies profile during systemic lupus erythematosus and psoriasis diseases in Egypt","volume":"34","author":"Farid","year":"2022","journal-title":". J King Saud Univ - Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.08.002","article-title":"High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein","volume":"34","author":"Novick","year":"2010","journal-title":"J Autoimmun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04742.x","article-title":"IL-18 activity in systemic lupus erythematosus","author":"Favilli","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.3390\/ijms252413505","article-title":"IL-18 and IL-18BP: A unique dyad in health and disease","volume":"25","author":"Novick","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1631728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:28:53Z","timestamp":1760074133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1631728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2025.1631728"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1631728","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"article-number":"1631728"}}